Related Experiment Videos
Protease inhibitors diminish lymphocyte stimulation in vitro
H Tchórzewski1, E Fornalczyk, J Paśnik
1Department Pathophysiology and Immunology, Military Medical Academy, Lódź, Poland.
Immunology Letters
|June 1, 1995
Summary
Proteases are crucial for early lymphocyte activation and proliferation. Inhibiting thiol and serine proteases blocks PHA-induced stimulation, but this effect is reversed by Interleukin-2 (IL-2).
Area of Science:
- Immunology
- Molecular Biology
- Biochemistry
Background:
- Lymphocyte activation involves enzymatic signal transduction, gene activation, and protein production.
- Proteases play a key role in enzyme activation through protein cleavage and generating biologically active molecules.
Purpose of the Study:
- To investigate the role of proteases in peripheral blood mononuclear cell (PBMC) activation.
- To elucidate the involvement of thiol and serine proteases in early lymphocyte proliferation.
Main Methods:
- In vitro study using broad specificity inhibitors of thiol proteases (PHMB) and serine proteases (TLCK).
- Assessed the effect of inhibitors on phytohemagglutinin (PHA)-induced lymphocyte stimulation and Interleukin-2 (IL-2) production.
- Investigated the reversibility of PHMB and the irreversibility of TLCK.
Main Results:
- Both PHMB and TLCK inhibited PHA-induced lymphocyte stimulation when added at the start of culture.
- The inhibitory effect was abolished when inhibitors were added 4 hours later.
- Exogenous IL-2 reversed the inhibition caused by proteases.
- PHMB inhibition was reversible, while TLCK inhibition was irreversible.
- Inhibition of T lymphocyte-enriched proliferation was more pronounced than in PBMCs.
Conclusions:
- Proteases are involved in the early stages of lymphocyte proliferation.
- Protease activity is essential for Interleukin-2 (IL-2) production, which regulates cell growth.
- Targeting proteases may offer insights into modulating lymphocyte activation and immune responses.